![](https://investorshub.advfn.com/uicon/691940.png?cb=1578604518)
Sunday, July 09, 2023 10:15:36 PM
On May 17, the AANS, the CNS, the AANS/CNS Joint Section on Pain and the AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves endorsed H.R. 3259, the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act. Sponsored by Reps. Terri Sewell (D-Ala.), David McKinley (R-W.V.), Ann Kuster (D-N.H.) and Brian Fitzpatrick (R-Pa.), the NOPAIN Act would require Medicare to provide adequate facility reimbursement for innovative and effective alternatives to opioids. In the letter, the neurosurgical groups pointed out that neurosurgeons are on the cutting edge of innovative, non-opioid treatments for chronic pain and acute postoperative pain. In March, the neurosurgical groups endorsed the Senate version of this legislation.
Do your own due diligence when investing. My posts are my opinion!!
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM